Evidence-based recommendations on categories for extent of resection in diffuse glioma

Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma

(2020) Jinhyun Choi et al.   Scientific Reports

Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma

(2020) Annette M. Molinaro et al.   JAMA Oncology

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

(2020) David N. Louis et al.   BRAIN PATHOLOGY

Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery

(2020) Luca Zigiotto et al.   JOURNAL OF NEURO-ONCOLOGY

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions

(2020) Patrick Y Wen et al.   NEURO-ONCOLOGY

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

(2020) Michael Weller et al.   Nature Reviews Clinical Oncology

Role of postoperative tumor volume in patients with MGMT-unmethylated glioblastoma

(2019) Arthur H. A. Sales et al.   JOURNAL OF NEURO-ONCOLOGY

Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research

(2019) A. Lasocki et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study

(2019) Philipp Kickingereder et al.   LANCET ONCOLOGY

Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement

(2019) Ken Chang et al.   NEURO-ONCOLOGY

Accuracy of the neurosurgeons estimation of extent of resection in glioblastoma

(2019) Sümeyye Sezer et al.   ACTA NEUROCHIRURGICA

Survival of diffuse astrocytic glioma, IDH1/2-wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

(2019) C Mircea S Tesileanu et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

(2019) Quinn T Ostrom et al.   NEURO-ONCOLOGY

Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome

(2018) Aikaterini Kotrotsou et al.   JOURNAL OF NEURO-ONCOLOGY

Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI

(2018) Yu Fujii et al.   JOURNAL OF NEUROSURGERY

Extent of surgery in low-grade gliomas: an old question in a new context

(2018) Roberta Rudà et al.   NEURO-ONCOLOGY

Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification

(2018) Jung Ho Im et al.   Scientific Reports

OUP accepted manuscript

(2018)   NEUROSURGERY

The Evolving Role of the Oncologic Neurosurgeon: Looking Beyond Extent of Resection in the Modern Era

(2018) Stephen G. Bowden et al.   Frontiers in Oncology

Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning

(2018) Bogdana Suchorska et al.   EUROPEAN JOURNAL OF CANCER

Supratotal resection in glioma: a systematic review

(2018) Charles N de Leeuw et al.   NEURO-ONCOLOGY

Higher-Order Surgical Questions for Diffuse Low-Grade Gliomas

(2018) Hugues Duffau   NEUROSURGERY CLINICS OF NORTH AMERICA

Diffuse Infiltrating Oligodendroglioma and Astrocytoma

(2017) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience

(2017) Federico Pessina et al.   JOURNAL OF NEURO-ONCOLOGY

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

(2017) Maarten M J Wijnenga et al.   NEURO-ONCOLOGY

Surgical resection of incidental diffuse gliomas involving eloquent brain areas. Rationale, functional, epileptological and oncological outcomes

(2017) G.L.O. Lima et al.   NEUROCHIRURGIE

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy

(2016) Federico Pessina et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis

(2016) Christine Jungk et al.   JOURNAL OF NEURO-ONCOLOGY

Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion

(2016) Tomohiro Kawaguchi et al.   JOURNAL OF NEURO-ONCOLOGY

The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

(2016) Yan Michael Li et al.   JOURNAL OF NEUROSURGERY

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

(2016) Nathalie L. Albert et al.   NEURO-ONCOLOGY

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial

(2016) Bogdana Suchorska et al.   NEURO-ONCOLOGY

Contribution of combined intraoperative electrophysiological investigation with 3-T intraoperative MRI for awake cerebral glioma surgery: comprehensive review of the clinical implications and radiological outcomes

(2016) Diana Ghinda et al.   Neurosurgical Focus

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

(2016) Jan C. Buckner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma

(2016) Ilker Y. Eyüpoglu et al.   Oncotarget

Extent of Resection and Survival in Glioblastoma Multiforme

(2016) Giovanni Grasso   JAMA Oncology

Association of the Extent of Resection With Survival in Glioblastoma

(2016) Timothy J. Brown et al.   JAMA Oncology

Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma – A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy

(2016) Roland Roelz et al.   Scientific Reports

Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up

(2015) Hugues Duffau   ACTA NEUROCHIRURGICA

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities

(2015) David E. Reuss et al.   ACTA NEUROPATHOLOGICA

Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM

(2015) B. Suchorska et al.   NEUROLOGY

Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery

(2014) Nicholas F. Marko et al.   JOURNAL OF CLINICAL ONCOLOGY

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity

(2014) Mark E. Oppenlander et al.   JOURNAL OF NEUROSURGERY

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma

(2014) Matthew M. Grabowski et al.   JOURNAL OF NEUROSURGERY

An Intra-Individual Comparison of MRI, [18F]-FET and [18F]-FLT PET in Patients with High-Grade Gliomas

(2014) Martha Nowosielski et al.   PLoS One

Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor

(2014) Rajan Jain et al.   RADIOLOGY

Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy†

(2013) F. -W. Kreth et al.   ANNALS OF ONCOLOGY

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma

(2013) Kaisorn L. Chaichana et al.   NEURO-ONCOLOGY

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection

(2013) Jason Beiko et al.   NEURO-ONCOLOGY

Survival and Prognostic Factors of Anaplastic Gliomas

(2013) Miriam Nuño et al.   NEUROSURGERY

Impact of extent of resection for recurrent glioblastoma on overall survival

(2012) Orin Bloch et al.   JOURNAL OF NEUROSURGERY

Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival

(2012) Daniel Orringer et al.   JOURNAL OF NEUROSURGERY

An extent of resection threshold for newly diagnosed glioblastomas

(2011) Nader Sanai et al.   JOURNAL OF NEUROSURGERY

Awake surgery for WHO Grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection

(2011) Yordanka N. Yordanova et al.   JOURNAL OF NEUROSURGERY

Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas

(2011) Michael A. Vogelbaum et al.   NEUROSURGERY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

(2008) Justin S. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial

(2008) Edward G. Shaw et al.   JOURNAL OF NEUROSURGERY